Challenging conditions notwithstanding, advanced data science provides cause for optimism this year for consumer packaged goods marketers. That is the message of IRI’s latest Times & Trends report, “Taking Stock of CPG Past and Future: Gear Up Now for a Year of Growth.
Clearly, health care reform will remain a contentious issue during the current presidential election cycle and beyond. The House of Representatives started the new year by voting to gut the Affordable Care Act.
The new year has begun inauspiciously for chain drug retailing, an industry that is still trying to assess the results of the just completed Christmas selling season. By all accounts, December was a month of no great accomplishments, even if it was not the disaster some observers predicted.
The mobile experience, including both websites and apps, can play a prominent role for those tracking their fitness and wellness, managing multiple medications, and/or managing an illness or chronic condition. According to Pew Research Center, nearly two-thirds of Americans own a smartphone.
In many significant ways, the chain drug store business looks very different at the start of 2016 than it did a year ago.
Christmas is over, yesterday’s news. And the mass retailing community is scampering to assess its impact on sales, earnings and the future. For chain drug retailers, this holiday selling season, like so many before it, was acceptable, if hardly record-setting.
Putting patients increasingly in control of their well-being and health care outcomes has truly come of age.
one with outstanding growth potential for pharmacies that build strong differentiating capabilities. The Mexican pharmaceutical market grew 3% annually over the past few years to reach $14
It is said that patience is a virtue. With respect to medication therapy management (MTM) by chain pharmacists, patience has been more a necessity than a virtue. Among and between health care providers, including pharmacists, there have been MTM pilot projects and some test collaborations.
The retailing business in the United States may have reached an inflection point during the period around Black Friday, traditionally seen as the start of the holiday selling season.
and very little was as it had been a year ago. Many of the same familiar faces were on hand, and several of the same retail companies attended. But the yearlong series of events that have
More than five years after enactment of the Affordable Care Act, a measure designed to extend coverage to the uninsured and control expenditures, the turmoil in the U.S. health care system shows no signs of abating.
again. But the current promotion bears little resemblance to the event that, apparently eons ago, ushered in the Christmas selling season by offering shoppers, for a limited time on the day following Thanksgiving, holiday specials that lured customers into all manner of stores.
The spectacular is becoming so commonplace that even the most astonishing events in chain drug retailing are assuming a ho-hum characteristic. Nothing new here, even if Walgreens has announced its intention to acquire Rite Aid.
Stefano Pessina is once again changing the face of community pharmacy.
The move toward closer cooperation among providers is one of the more intriguing developments in health care, one that promises to improve patient outcomes and limit expenditures in a sector that accounts for almost 20% of the nation’s gross domestic product.
